Does EVOLOCUMAB Cause Accidental exposure to product? 16,160 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16,160 reports of Accidental exposure to product have been filed in association with EVOLOCUMAB (REPATHA). This represents 10.8% of all adverse event reports for EVOLOCUMAB.
16,160
Reports of Accidental exposure to product with EVOLOCUMAB
10.8%
of all EVOLOCUMAB reports
3
Deaths
154
Hospitalizations
How Dangerous Is Accidental exposure to product From EVOLOCUMAB?
Of the 16,160 reports, 3 (0.0%) resulted in death, 154 (1.0%) required hospitalization, and 8 (0.0%) were considered life-threatening.
Is Accidental exposure to product Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 16,160 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
Device use error (4,002)
What Other Drugs Cause Accidental exposure to product?
DUPILUMAB (10,747)
ERENUMAB-AOOE (9,923)
ETANERCEPT (6,065)
PEGFILGRASTIM (4,967)
GUSELKUMAB (2,941)
SECUKINUMAB (2,397)
GOLIMUMAB (1,578)
USTEKINUMAB (1,352)
FREMANEZUMAB-VFRM (1,346)
DENOSUMAB (1,330)
Which EVOLOCUMAB Alternatives Have Lower Accidental exposure to product Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE